V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003355 | 10002139 | 1.75 | 76.5 | Curative (C) | 2017-09-03 | 2017-09-12 | Imatinib 400mg | N | N | 10472685 | FLUOROURACIL + MITOMYCIN + RT |
| 10003356 | 10002140 | 1.78 | null | Curative (C) | 2018-05-24 | 2018-05-24 | CAPECITABINE + RT | N | N | 10472740 | CAPECITABINE + RT |
| 10003357 | 10002141 | 1.54 | 68.7 | Curative (C) | 2017-07-24 | 2017-08-13 | Cisplatin + Radiotherapy | N | Y | 10472826 | CISPLATIN + RT |
| 10003358 | 10002142 | 1.6 | 64.1 | Adjuvant (A) | 2018-05-18 | 2018-05-20 | Temozolomide + RT | 2 | null | 10472828 | TEMOZOLOMIDE + RT |
| 10003359 | 10002143 | 1.63 | 66.7 | Curative (C) | 2017-11-30 | 2017-12-14 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10472876 | CVD |
| 10003360 | 10002144 | 1.67 | 54 | Neo-adjuvant (N) | 2016-11-25 | 2016-11-25 | CISPLATIN + ETOPOSIDE | N | N | 10472954 | EC |
| 10003361 | 10002145 | null | null | Adjuvant (A) | 2017-10-30 | 2017-11-11 | Abiraterone | 02 | N | 10473010 | CISPLATIN + ETOPOSIDE |
| 10003362 | 10006408 | 1.79 | 86 | Curative (C) | 2017-04-21 | 2017-04-21 | CAPECITABINE + RT | N | Y | 10473064 | CAPECITABINE + RT |
| 10003363 | 10006408 | 1.78 | 78 | Palliative (P) | 2018-01-15 | 2018-06-18 | FLUOROURACIL + IRINOTECAN | 2 | Y | 10473064 | IRINOTECAN + MDG |
| 10003364 | 10008797 | 0 | 73.8 | Adjuvant (A) | 2014-04-06 | 2014-04-07 | MaxiCHOP (Cycle 1) | 02 | N | 10473073 | CTD |
| 10003365 | 10008797 | 1.77 | 102.1 | Adjuvant (A) | 2016-10-03 | 2016-10-15 | FEC 100 + DOCETAXEL | 02 | N | 10473073 | FEC + DOCETAXEL |
| 10003366 | 10002146 | 1.64 | 81 | Curative (C) | 2018-10-15 | 2018-11-04 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 10473167 | CISPLATIN + RT |
| 10003367 | 10002146 | 1.58 | 55 | Curative (C) | 2017-01-31 | 2017-02-03 | CISPLATIN + RT | N | Y | 10473167 | CISPLATIN + RT |
| 10003368 | 10002147 | 1.78 | 68 | Curative (C) | 2016-03-25 | 2016-03-26 | CISPLATIN + RT | 2 | null | 10473435 | CISPLATIN + RT |
| 10003369 | 10002147 | 1.8 | null | Palliative (P) | null | 2018-07-02 | Irinotecan + Modified De Gramont | N | null | 10473435 | IRINOTECAN + MDG |
| 10003370 | 10002147 | 1.81 | 0 | Adjuvant (A) | 2018-12-23 | 2018-12-30 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10473435 | FLUOROURACIL |
| 10003371 | 10002147 | 0 | 64 | Palliative (P) | 2013-10-31 | 2013-11-11 | Bortezomib +/- Dexamethasone | N | N | 10473435 | AZACITIDINE |
| 10003372 | 10002148 | 1.76 | 79.5 | Curative (C) | 2017-05-07 | 2017-05-28 | Cisplatin 100 + RT(H&N) 1 day | N | N | 10473671 | CISPLATIN + RT |
| 10003373 | 10002148 | 1.59 | 68.9 | Adjuvant (A) | 2014-05-05 | 2014-05-20 | FLUOROURACIL | 02 | N | 10473671 | FLUOROURACIL |
| 10003374 | 10002149 | 1.71 | 78 | Palliative (P) | 2015-01-07 | 2015-01-26 | Paclitaxel 7 day | N | N | 10473797 | ABVD |
| 10003375 | 10002149 | 1.62 | 62.8 | Curative (C) | 2016-10-13 | 2016-10-13 | IMATINIB | 2 | N | 10473797 | PACLITAXEL |
| 10003376 | 10002149 | 1.52 | 0 | null | 2015-08-27 | 2015-08-28 | Cisplatin + Radiotherapy + CISPLATIN | 02 | null | 10473797 | CISPLATIN + RT |
| 10003377 | 10002150 | 1.66 | 76.4 | Disease modification (D) | 2017-01-04 | 2017-01-11 | CHOP - 21 days | 02 | N | 10473958 | CAPECITABINE + GEMCITABINE |
| 10003378 | 10002150 | null | 82 | null | 2016-02-10 | 2016-02-11 | EC | null | N | 10473958 | CHOP |
| 10003379 | 10002151 | 1.63 | 56.8 | Curative (C) | 2016-09-29 | 2016-10-27 | Capecitabine 35days + RT | N | Y | 10474067 | CAPECITABINE + RT |
| 10003380 | 10006414 | null | 77.3 | Unknown (U) | null | 2014-08-15 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10474073 | BORTEZOMIB |
| 10003381 | 10002152 | 1.72 | 71 | Adjuvant (A) | null | 2016-10-20 | ABVD | N | N | 10474114 | CAPECITABINE + GEMCITABINE |
| 10003382 | 10002153 | null | 0 | Disease modification (D) | null | 2017-08-21 | CTD | N | N | 10474176 | CTD |
| 10003383 | 10002154 | 1.75 | 86.6 | Palliative (P) | 2013-11-26 | 2013-11-27 | Bortezomib (weekly) | 2 | N | 10474327 | CHOP |
| 10003384 | 10002155 | 1.75 | 64.5 | Palliative (P) | 2015-01-19 | 2015-02-01 | Paclitaxel 7 day | N | N | 10474577 | PACLITAXEL |
| 10003385 | 10002156 | 1.69 | 81.5 | Palliative (P) | null | 2017-06-04 | Abiraterone | N | Y | 10474602 | BORTEZOMIB |
| 10003386 | 10002157 | null | 64.9 | null | 2017-11-18 | 2017-12-15 | CAPECITABINE + RT | null | Y | 10474607 | CAPECITABINE + RT |
| 10003387 | 10002158 | 1.71 | 88 | Curative (C) | 2016-09-14 | 2016-09-14 | FEC + DOCETAXEL | N | N | 10474727 | FEC + DOCETAXEL |
| 10003388 | 10002158 | 1.57 | 130.8 | Adjuvant (A) | 2018-02-28 | 2018-02-28 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10474727 | CAPECITABINE + CISPLATIN |
| 10003389 | 10008082 | 1.64 | 89.6 | Palliative (P) | 2018-06-19 | 2018-07-03 | Irinotecan + Modified De Gramont | N | N | 10474818 | IRINOTECAN + MDG |
| 10003390 | 10002159 | 1.81 | 97 | Disease modification (D) | null | 2014-07-23 | Paclitaxel 7 day | N | N | 10474833 | CHLORAMBUCIL |
| 10003391 | 10002160 | 1.72 | 60.9 | Palliative (P) | 2015-06-14 | 2015-06-14 | CISPLATIN + ETOPOSIDE | 02 | N | 10474883 | CISPLATIN |
| 10003392 | 10002160 | 1.69 | 63.9 | Adjuvant (A) | 2017-05-21 | 2017-05-21 | Capecitabine + Cisplatin | N | N | 10474883 | CAPECITABINE + CISPLATIN |
| 10003393 | 10002161 | 1.64 | 111.2 | Adjuvant (A) | 2018-12-09 | 2018-12-19 | Capecitabine + Cisplatin | 2 | N | 10474928 | PACLITAXEL |
| 10003394 | 10002161 | 1.68 | 72 | Palliative (P) | 2017-10-08 | 2017-10-08 | Cisplatin + Etoposide po&iv 3 day | N | N | 10474928 | CTD |
| 10003395 | 10002161 | 1.8 | 0 | Disease modification (D) | 2016-10-17 | 2016-10-19 | Abiraterone | N | N | 10474928 | CTD |
| 10003396 | 10002162 | 1.6 | 64.1 | Adjuvant (A) | 2017-05-08 | 2017-05-13 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10475365 | PACLITAXEL |
| 10003397 | 10002162 | 1.66 | 0 | Neo-adjuvant (N) | 2017-02-22 | 2017-02-25 | CHOP - 14 days | N | N | 10475365 | CVD |
| 10003398 | 10002162 | 1.79 | 55 | Palliative (P) | 2018-01-27 | 2018-06-30 | Irinotecan + Modified De Gramont | 2 | Y | 10475365 | IRINOTECAN + MDG |
| 10003399 | 10002163 | 1.61 | 62.2 | Curative (C) | 2015-01-07 | 2015-01-30 | Cisplatin + Radiotherapy | N | Y | 10475530 | CISPLATIN + RT |
| 10003400 | 10002163 | null | null | Curative (C) | 2017-12-04 | 2017-12-25 | ABVD | 02 | N | 10475530 | EC |
| 10003401 | 10002163 | 1.63 | 71.3 | Palliative (P) | 2015-07-24 | 2015-07-24 | Bortezomib +/- Dexamethasone | 2 | N | 10475530 | CHOP |
| 10003402 | 10002163 | null | null | Neo-adjuvant (N) | null | 2018-09-05 | CAPECITABINE + RT | null | null | 10475530 | CAPECITABINE + RT |
| 10003403 | 10002163 | 1.75 | 82.2 | Curative (C) | 2018-05-10 | 2018-06-10 | FEC + DOCETAXEL | N | N | 10475530 | FEC + DOCETAXEL |
| 10003404 | 10002164 | null | 96.3 | null | null | 2016-11-16 | Capecitabine 35days + RT | N | N | 10475824 | CAPECITABINE + RT |